How Profitable Is Elanco Animal Health (ELAN)?

Elanco Animal Health, a mid-cap Drug Manufacturing company, moved 0.3 during today's afternoon session. The company's business may appear to be profitable at first glance, since its most recent operating margins stand at 6.3%. But there is more to the story.

Date Reported Total Revenue ($ MM) Operating Expenses ($ MM) Operating Margins (%) YoY Growth (%)
2021-12-31 4,765 2,329 6.34 369.79
2020-12-31 3,273 1,684 -2.35 -119.5
2019-12-31 3,071 1,231 12.05 17.79
2018-12-31 3,067 1,179 10.23 n/a
Date Reported Cash Flow from Operations ($ MM) Capital expenditures ($ MM) Free Cash Flow ($ MM) YoY Growth (%)
2021-12-31 483 -197 286 181.27
2020-12-31 -41 -311 -352 -1417.98
2019-12-31 224 -197 27 -92.43
2018-12-31 487 -134 353 n/a

Elanco Animal Health's margins may be growing at an average rate of 89.4%, but its free cash flows are shrinking at an average rate of -443.0%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.